Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction …

C Zhou, X Shi, H Huang, Y Zhu, Y Wu - Anesthesia & Analgesia, 2014 - journals.lww.com
BACKGROUND: Cysteinyl leukotrienes and their receptors have been shown to be involved
in the generation of neuropathic pain. We performed this study to determine the antagonistic …

Ameliorative potential of montelukast on ischemia–reperfusion injury induced vasculitic neuropathic pain in rat

A Muthuraman, M Ramesh, S Sood - Life sciences, 2012 - Elsevier
AIMS: Ischemia-reperfusion (I/R) event in vascular and nervous system has been
documented to rising ischemic and vasculitic neuropathic pain, clinically resembles the …

Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/KATP …

E Alizamani, B Ghorbanzadeh… - International Journal …, 2021 - Taylor & Francis
Objective The leukotrienes are inflammatory mediators. In the present study, the analgesic
role of local montelukast, a cysteinyl leukotriene receptor antagonist, and the possible …

The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic …

L Xu, Y Huang, X Yu, J Yue, N Yang… - Anesthesia & …, 2007 - journals.lww.com
BACKGROUND: Tumor necrosis factor α (TNF-α) could trigger p38 mitogen-activated
protein kinase (MAPK) activation. Conversely phosphorylated p38 (p-p38) could induce the …

Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord

WL Dai, YN Bao, JF Fan, SS Li, WL Zhao… - Regional Anesthesia & …, 2020 - rapm.bmj.com
Background and objectives Neuropathic pain is partially refractory to currently available
treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 …

Lidocaine suppresses the increased extracellular signal-regulated kinase/cyclic AMP response element-binding protein pathway and pro-inflammatory cytokines in a …

JD Joo, JW Choi, JH In, HS Jung, JA Lee… - European Journal of …, 2011 - journals.lww.com
Methods Twenty-four male Sprague–Dawley rats were randomly allocated to three groups
(eight per group): sham-operated (control) group, a neuropathic pain and normal saline …

Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA/p38MAPK signaling pathway

X Li, H Shi, D Zhang, B Jing, Z Chen… - CNS Neuroscience …, 2023 - Wiley Online Library
Background This study aimed to investigate the potential mechanism of paeonol in the
treatment of neuropathic pain. Methods Relevant mechanisms were explored through …

Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain

K Noguchi, M Okubo - Biological and Pharmaceutical Bulletin, 2011 - jstage.jst.go.jp
The purpose of this review is to summarize the recent studies examining the expression of
leukotrienes (LTs) and their receptors in nociceptive pathways, and their crucial roles in …

Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury

M Erşahin, Ö Çevik, D Akakın, A Şener, L Özbay… - Prostaglandins & other …, 2012 - Elsevier
Spinal cord injury (SCI) leads to an inflammatory response that generates substantial
secondary damage within the tissue besides the primary damage. Leukotrienes are …

Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain

XP Mei, Y Zhou, W Wang, J Tang, W Wang, H Zhang… - Neurosignals, 2011 - karger.com
Reports suggest that microglia play a key role in spinal nerve ligation (SNL)-induced
neuropathic pain, and toll-like receptor 3 (TLR3) has a substantial role in the activation of …